Diethylamine nonoate/fasudil - VBS Pharmaceuticals
Alternative Names: Diethylamine nonoate/fasudil encapsulated liposome - VBS PharmaceuticalsLatest Information Update: 17 Sep 2024
At a glance
- Originator VBS Pharmaceuticals
- Class Amines; Anti-ischaemics; Antivirals; Diethylamines; Hydrazines; Ischaemic heart disorder therapies; Isoquinolines; Nitroso compounds; Small molecules; Sulfonamides
- Mechanism of Action Calcium channel antagonists; Protein kinase C inhibitors; Rho-associated kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical COVID 2019 infections; Pulmonary arterial hypertension; Sepsis
Most Recent Events
- 12 Sep 2024 Preclinical trials in COVID-2019 infections in USA (Inhalation) prior to September 2024 (Vascular BioSciences pipeline, September 2024)
- 12 Sep 2024 Preclinical trials in COVID-2019 infections in USA (IV) prior to September 2024 (Vascular BioSciences pipeline, September 2024)
- 12 Sep 2024 Preclinical trials in Pulmonary arterial hypertension in USA (Inhalation) prior to September 2024 (Vascular BioSciences pipeline, September 2024)